23 November 2024NewsAmericasChristina MacDougall, Partner, Morgan Lewis | Susan Evans, Senior Director, Intellectual Property, IGM Biosciences | Lawrence Rozsnyai, Vice President of Intellectual Property, Lycia Therapeutics | Reena Bajpai, Senior Counsel II, Gilead Sciences
WATCH: Strategies for success - patent drafting and application
Panellists from IGM Biosciences, Lycia Therapeutics, Gilead Sciences, and Morgan Lewis delve into how thoughtful patent drafting can improve prosecution outcomes and strengthen overall IP strategy.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com
17 June 2026 A cancer diagnostics company has lost its bid to overturn a jury verdict in a major patent dispute that has also spawned parallel proceedings before the Federal Circuit and PTAB.
12 June 2026 In a strong response to BioNTech, Moderna argues its next-gen vaccine is built on a fundamentally different design from the German biotech’s—setting up a scrap over whether a key patent should have been granted.